Bunkerhill Abdominal Aortic Quantification (AAQ) vs PMcardio

PMcardio offers a mobile app and web platform, making it highly accessible for clinicians at the point of care, and supports various ECG formats, including images of old or damaged ECG strips. Bunkerhill AAQ is cloud-based and integrates with the Carebricks platform and EHRs, but its primary interaction seems to be through existing radiology workflows rather than a dedicated, clinician-facing application. PMcardio's freemium model also allows individual clinicians to easily try and adopt the tool, contributing to its usability.

PMcardio has been rigorously validated in over 25 independent, peer-reviewed clinical studies, demonstrating superior accuracy in detecting over 50 cardiac conditions, including STEMI and reduced LVEF, outperforming standard-of-care methods. Bunkerhill AAQ is FDA-cleared for automated abdominal aortic diameter quantification on CT scans, enabling early aneurysm detection and streamlined follow-up. While both offer significant clinical value, PMcardio's extensive validation and broader range of detectable conditions suggest a wider immediate clinical impact across various care settings.

PMcardio offers a transparent freemium model with a free plan for up to 5 ECG analyses per month and a Pro Plan for unlimited use, providing clear pricing for individuals and teams. Bunkerhill AAQ's pricing is custom and requires direct contact, which can be a barrier to initial adoption and transparency. PMcardio's accessible pricing structure and free trial option offer greater immediate value and flexibility for a wider range of users.

Both tools demonstrate enterprise readiness through their integration capabilities and compliance. Bunkerhill AAQ integrates with the Carebricks platform and EHRs, and has FDA clearance, indicating its suitability for enterprise deployment. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, is HIPAA and GDPR compliant, and has CE certification, with a dedicated plan for organizations. Both are well-positioned for enterprise adoption, catering to different clinical workflows and data handling needs.

Bunkerhill AAQ is notable for being the first FDA-cleared AI to automate abdominal aortic diameter quantification on both contrast and non-contrast CT scans, enabling opportunistic screening for silent aneurysms from routine CTs. This approach of leveraging existing imaging for new screening purposes represents a significant innovation in proactive disease detection. While PMcardio's AI explainability feature (ECGxplainu2122) is innovative, Bunkerhill's focus on opportunistic screening from routine scans offers a novel paradigm shift in early detection.

PMcardio provides a comprehensive Help Center with user-friendly tutorials and manuals, an FAQ section, and a blog with in-depth information. This indicates a strong commitment to user support and readily available documentation. While Bunkerhill Health's integration with the Carebricks platform implies some level of support, specific details about publicly accessible documentation or a dedicated help center are not as readily available in the provided information.